Envoy Medical Enters Material Agreement, Reports Equity Sales

Ticker: COCHW · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1840877

Sentiment: neutral

Topics: material-agreement, financial-obligation, equity-sale

TL;DR

Envoy Medical inked a big deal June 26, 2025, and sold some stock. Watch this space.

AI Summary

Envoy Medical, Inc. entered into a material definitive agreement on June 26, 2025, related to a direct financial obligation. The company, formerly Anzu Special Acquisition Corp I, is involved in the orthopedic, prosthetic & surgical appliances & supplies industry. This filing also notes unregistered sales of equity securities and includes financial statements and exhibits.

Why It Matters

This filing indicates a significant financial event for Envoy Medical, potentially impacting its financial obligations and equity structure. Investors should monitor the details of the agreement and equity sales.

Risk Assessment

Risk Level: medium — The filing details material definitive agreements and unregistered equity sales, which can introduce financial and operational risks.

Key Players & Entities

FAQ

What type of material definitive agreement did Envoy Medical, Inc. enter into?

The filing indicates the entry into a material definitive agreement on June 26, 2025, which also constitutes the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement.

What is the former name of Envoy Medical, Inc.?

Envoy Medical, Inc. was formerly known as Anzu Special Acquisition Corp I, with a date of name change on January 15, 2021.

What is Envoy Medical, Inc.'s Standard Industrial Classification code?

Envoy Medical, Inc. falls under SIC code 3842, which is for Orthopedic, Prosthetic & Surgical Appliances & Supplies.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 26, 2025.

What other types of information are included in this 8-K filing besides the material agreement?

This 8-K filing also includes information on the creation of a direct financial obligation, unregistered sales of equity securities, and financial statements and exhibits.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding Envoy Medical, Inc. (COCHW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing